|
|
||||||||
Papers In Press, published online ahead of print July 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology Program, Dept of Surgery, Children's Hospital, Boston, MA
Corresponding Author: karen.moulton{at}childrens.harvard.edu
Retention of lipoproteins to proteoglycans in the subendothelial matrix is an early event in atherosclerosis. We recently reported collagen XVIII and its proteolytically-released fragment endostatin are differentially depleted in blood vessels affected by atherosclerosis. Loss of collagen XVIII/endostatin in atherosclerosis-prone mice enhanced plaque neovascularization and increased vascular permeability to lipids by distinct mechanisms. Impaired endothelial barrier function increased the influx of lipoproteins across the endothelium; however, we hypothesized that enhanced retention might be a second mechanism leading to the increased lipid content in atheromas lacking collagen XVIII. We now demonstrate a novel property of endostatin that binds both the matrix proteoglycan biglycan and LDL and interferes with LDL retention to biglycan and to subendothelial matrix. A peptide encompassing the alpha coil in the endostatin crystal structure mediates the major blocking effect of endostatin on LDL retention. Endostatin inhibits macrophage uptake of biglycan-associated LDL indirectly by interfering with LDL retention to biglycan, but it has no direct effect on macrophage uptake of native or modified lipoproteins. Thus, loss of endostatin in advanced atheromas enhances lipoprotein retention in subendothelial matrix. Our data reveals a third protective role of this vascular basement membrane component during atherosclerosis.
Accepted on June 27, 2005
Endostatin binds biglycan and LDL and interferes with LDL retention to subendothelial matrix during atherosclerosis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Yokoyama, G. Sedgewick, and S. Ramakrishnan Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination Cancer Res., November 15, 2007; 67(22): 10813 - 10822. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, J. A. Hall, N. Levenkova, E. Lee, M. K. Middleton, A. M. Zukas, D. J. Rader, J. J. Rux, and E. Pure CD44 Regulates Vascular Gene Expression in a Proatherogenic Environment Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 886 - 892. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |